Current advances of epigenetics in periodontology from ENCODE project: a review and future perspectives by Cho, Young-Dan et al.
Cho et al. Clin Epigenet           (2021) 13:92  
https://doi.org/10.1186/s13148-021-01074-w
REVIEW
Current advances of epigenetics 
in periodontology from ENCODE project: 
a review and future perspectives
Young‑Dan Cho1, Woo‑Jin Kim2, Hyun‑Mo Ryoo2, Hong‑Gee Kim3, Kyoung‑Hwa Kim1, Young Ku1 and 
Yang‑Jo Seol1*  
Abstract 
Background: The Encyclopedia of DNA Elements (ENCODE) project has advanced our knowledge of the functional 
elements in the genome and epigenome. The aim of this article was to provide the comprehension about current 
research trends from ENCODE project and establish the link between epigenetics and periodontal diseases based on 
epigenome studies and seek the future direction.
Main body: Global epigenome research projects have emphasized the importance of epigenetic research for under‑
standing human health and disease, and current international consortia show an improved interest in the importance 
of oral health with systemic health. The epigenetic studies in dental field have been mainly conducted in periodontol‑
ogy and have focused on DNA methylation analysis. Advances in sequencing technology have broadened the target 
for epigenetic studies from specific genes to genome‑wide analyses.
Conclusions: In line with global research trends, further extended and advanced epigenetic studies would provide 
crucial information for the realization of comprehensive dental medicine and expand the scope of ongoing large‑
scale research projects.
Keywords: Chronic disease, Epigenetics, ENCODE project, Next‑generation sequencing, Periodontology, Personalized 
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Background
The Encyclopedia of DNA Elements (ENCODE) project 
has advanced our knowledge of the functional elements 
in the genome and epigenome, including chromatin 
organization and gene regulatory elements [1]. Along 
with this trend of research, epigenetic approaches to 
dental research have been activated, suggesting a bright 
future direction for an in-depth understanding of the dis-
eases. Following the ENCODE project, global epigenome 
research projects, such as the NIH Roadmap Epigenome 
Program and International Human Epigenome Consor-
tium, emphasized the importance of epigenetic research 
for understanding human health and disease [2]. Current 
international consortia show an improved interest in the 
importance of oral health with systemic health, and the 
trend of epigenetic research continues in the dental field. 
Among them, a number of epigenetic studies have been 
conducted in the field of periodontology [3, 4]. Periodon-
tal disease, a representative chronic oral disease common 
in the elderly population characterized by inflammation 
and periodontal tissue destruction, is mainly caused by a 
multifactorial bacterial infection [5]. Periodontal diseases 
are also related to systemic chronic diseases, such as non-
communicable diseases, cardiovascular disease, diabetes 
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mellitus, and other metabolic syndromes [6–8]. These 
chronic diseases are usually persistent or long-lasting and 
are related to various environmental conditions, suggest-
ing the possibility of association with epigenetic changes 
[9]. Therefore, further extended and advanced epigenetic 
studies in periodontology would provide crucial informa-
tion for the realization of comprehensive dental medicine 
and expand the scope of ongoing large-scale research 
projects. In this review, we describe the contributions of 
the ENCODE project and cutting-edge technologies to 
human health, broadly, and periodontology, in particular. 
Furthermore, we establish the link between epigenomic 
changes and periodontal diseases based on recent 
researches and seek the future direction of development.
Periodontal disease: development and progression
Periodontitis is a representative, multifactorial, and 
chronic inflammatory disease with genetic and epigenetic 
factors (Fig. 1). It is well known that oral bacteria in den-
tal plaque induce periodontal disease and the consequent 
progression is associated with many risk factors, such as 
genetics, lifestyle, and systemic disease. If periodonti-
tis is not treated, several clinical signs, such as alveolar 
bone destruction, periodontal attachment loss, and tooth 
mobility, would follow [10].
Microbial challenge
Periodontal diseases are closely related to a wide ranges 
of microbiome profiles depending on the type of dis-
ease [11]. The microorganisms in the oral cavity have 
been named as oral microbiota, oral microflora, and 
oral microbiome recently. Oral microbiome refers to 
the collective genetic materials of oral microorganisms. 
The term microbiome is defined as the ecological com-
munity of microorganism residents and is widely used 
by the Human Microbiome Project [12, 13]. Socransky 
and Haffajee [14] classified the pathogens as five com-
plexes: yellow, green, purple, orange, and red, according 
to their presence in the biofilm. Generally, bacteria of 
yellow, green, purple complexes indicate comparatively 
healthy gingival tissue, whereas red and orange com-
plexes indicate periodontal pathogens [15]. Periodontal 
tissue destruction is predominantly caused by the host 
inflammatory reaction to the microbial challenge (Fig. 1). 
In the oral microbial biofilm, over 500 species of bacte-
ria are present, forming a dynamic community which 
adheres to teeth and periodontal tissue, and progresses 
into microbial colonization [16]. Therefore, a fundamen-
tal treatment of periodontal disease such as scaling or 
root planing is to remove dental plaque and calculus and 
reduce bacterial invasion of periodontal tissue.
Host response to microbial challenge
In addition to the microbial community in the environ-
mental flux, pathogen–host interaction is crucial to con-
trol periodontal disease. The oral epithelium is the first 
host cell to contact bacteria and acts as a physical and 
chemical barrier to separate the body from the micro-
bial infection [17]. The gingiva is divided into two main 








Clinical signs of 
Periodontal disease
(gingival redness, swelling, 






Disease phenotype Genotype Environmental factor Biological interaction
Ab, PMNs
HostBacteria
Fig. 1 Periodontal disease: development and progression. Generally, periodontal disease is initiated by microbial challenges and progresses with an 
immuno‑inflammatory response, which deteriorates connective tissue and causes bone destruction. During this process, genetic risk factors work 
in conjunction with epigenetic factors, and disease phenotype appears as comprehensive product of genotypic, environmental, and biological 
interaction. Ab, antibody; PMNs, polymorphonuclear cells; Ag, antigen; LPS, lipopolysaccharides; CK, cytokine; PG, prostaglandin; MMP, matrix 
metalloproteinases
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the surrounding of teeth and alveolar bone. Generally, 
junctional epithelium consists of specialized structures, 
such as adherence and gap junctions, which provide a 
favorable environment to the host immune system. Epi-
thelial cells and leukocytes stimulate their antimicrobial 
mechanism producing antibacterial peptides, such as 
α- and β-defensins, and cathelicidin, in response to an 
attack by pathogens [18]. Furthermore, various cytokines 
including interleukin-1,6,8 and tumor necrosis factor-α 
are involved in the development of an inflammatory 
response [19]. Therefore, host immune defense factors 
are essential in determining disease susceptibility, which 
is closely related to variation of signaling pathways and 
pathogen recognition receptors, and dictates the host 
response to the same bacterial infection. Thus far, genet-
ics has been limited and unable to explain this difference; 
hence, epigenetics was introduced to clarify the distinc-
tion of host response. Genetic factors are undoubtedly 
very important in the development of disease, but genetic 
changes can only be a risk factor when challenged by 
exogenous substances. Without inducing any changes in 
DNA sequences, epigenetic modifications can alter gene 
expression patterns which elicit a diverse host response 
[20]. Therefore, studies have been focused on regulation 
of gene expression, immune response, and disease sus-
ceptibility to the infections by epigenetic factors [21]. In 
addition, various efforts were made to find new epige-
netic biomarkers for the diagnosis, prognosis, and treat-
ment [22].
Changing research trend from genetics 
to epigenetics in periodontology
With advancing age, most people suffer from periodon-
tal disease, e.g., chronic periodontitis, and one or more 
other chronic systemic diseases could be involved [23]. 
Periodontitis is a representative chronic disease that 
is usually initiated by a bacterial challenge to the host 
(Fig.  1). Clinical signs of susceptibility and recurrence 
after treatment tend to be related to the causal micro-
organisms and inflammation [24]. Extensive studies 
have focused on genetic factors involved in periodontal 
disease, e.g., genes affecting inflammatory and immune 
responses, to develop treatment modalities [25]. As 
the immune system plays a potent role in the patho-
genesis of periodontitis, many studies have identified 
genetic polymorphisms associated with immunity [26]. 
Genetic factors are mainly associated with periodontal 
disease-related syndromes such as Papillon-Lefevre and 
Chediak-Higashi [27]. The genetic basis of periodontitis 
has been supported by familial aggregation or twin stud-
ies [28] and candidate gene studies [29]. Furthermore, 
genome-wide association (GWAS) studies have iden-
tified that genetic polymorphisms are associated with 
disease-related phenotypes [30–32]. GWAS studies have 
identified the genes for susceptibility of periodontal dis-
ease; NCR2 and EMR1 in chronic periodontitis [33] and 
GLT6D1 in aggressive periodontitis [34]. However, it has 
not been fully understood how genes affect pathogen-
esis. Many disease characteristics have a genetic basis, 
but variation in gene expression with respect to environ-
mental risk factors is not fully understood [35]. Similar 
to other chronic systemic diseases, periodontitis is typi-
cally associated with both genetic and epigenetic factors, 
including effects of environmental factors [22, 36]. Stud-
ies have shown that the pathogenesis of periodontal dis-
ease is complex, and susceptibility to periodontitis varies 
substantially among individuals with the same microbial 
infection [37]. Additionally, the host response varies 
according to environmental conditions. Among many 
environmental factors, smoking is the best known modi-
fiable risk factor for periodontal disease [37]. A strong 
association between smoking and periodontal disease 
has been reported [38, 39]. The association between peri-
odontal condition and other environmental factors, such 
as dietary habits, long-term medication, and systemic 
disease, has been discussed; however, precise molecular 
mechanism has not been clearly established [40]. Unlike 
genetic information, which is static within an individual, 
epigenetic information can be actively changed by envi-
ronmental conditions. Accordingly, epigenetics might be 
a crucial tool to explain how the environment influences 
the host response via changes in gene expression. As epi-
genetic research approach in the dental field is emerging, 
further studies of inflammation and disease biomarkers 
as well as studies of the effects of environmental factors 
on periodontal disease would bring the field into a new 
era [41, 42].
Epigenetics: linking environmental niches 
to human diseases
Many scientists were hoping that unresolved biological 
questions about genetic diseases would be settled after 
the completion of the Human Genome Project (HGP); 
however, these data did not provide clear answers [43, 
44]. Genomic sequences alone could not explain how 
DNA acts within chromatin and chromosomes, even 
though it is critical for cellular differentiation and devel-
opment. Therefore, new powerful methods to clarify the 
relationships of biological phenomena with genomic 
information were needed. Over time, a number of bio-
logical phenomena have been linked to epigenetics [45]. 
To understand phenotypes and biological processes for 
which genetic explanations are insufficient, epigenet-
ics has been quickly growing, with an understanding 
that environment factors can interact with the genome, 
resulting in epigenetic changes [46].
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Epigenetics is the study of phenotypic changes caused 
by alterations in gene expression, without changes in 
the DNA sequence [45]. Epigenetic changes mainly 
occur as an array of molecular mechanisms affecting 
both chromatin and DNA (Fig.  2). Three representative 
mechanisms, DNA methylation, histone modifications, 
and non-coding RNA-associated gene silencing, clearly 
induce and maintain epigenetic changes [45, 47, 48]. 
These epigenetic changes could occur naturally or could 
be influenced by environmental factors, individual life-
style, and chemical and physical factors. The changes 
could be localized to one generation and transmitted 
across generations. Increasing evidence based on ani-
mal and human studies indicates that prenatal and early 
postnatal environmental factors affect the risk of chronic 
diseases and behavioral disorders in adults [21, 49–52]. 
New and ongoing studies are continuously investigating 
the role of epigenetics in a variety of human diseases.
Encyclopedia of DNA Elements (ENCODE) project
To provide insight beyond the HGP, the ‘ENCODE’ pro-
ject has recently been launched after the completion of 
the HGP in 2003 by a worldwide collaborative research 
group funded by the National Human Genome Research 
Institute [1, 53, 54]. The aim of ENCODE is to generate a 
comprehensive list of all functional elements that act at 
the protein and RNA levels, including genes, transcripts, 
and transcriptional regulatory regions, together with 
Fig. 2 Mechanisms of epigenetics. The epigenetic modifications cause alterations in gene expression without directly altering the DNA sequence. 
In general, DNA methylation causes a segment of DNA to associate more closely with a histone complex. This prevents transcription factors from 
binding to a DNA sequence, such as a promoter, resulting in reduced expression of a specific gene. In contrast, histone acetylation weakens 
the interaction between the histone complex and DNA, allowing transcription factors to bind to the promoter and increase gene expression. 
Non‑coding RNAs also play a crucial role in the regulation of gene expression
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their chromatin histone states and DNA methylation pat-
terns in the human genome [55]. In other words, while 
the HGP sequenced the DNA in the human genome, 
the aim of ENCODE is to interpret these sequence data. 
Because about 20,000 genes provide the information 
to make proteins, accounting for only about 1% of the 
human genome, ENCODE was introduced to understand 
the remaining 99% of the genome. Initially, more than 
80% of the genome was mischaracterized as ‘junk DNA,’ 
but the non-coding genome actually has a crucial role in 
regulating gene activity and expression. The modulation 
of gene activity may regulate transcription, translation, 
and cellular functions and result in disease. Therefore, the 
ultimate goal of the ENCODE project is to link variation 
in gene expression to the development of disease [54]. At 
first, ENCODE pilot project in 2003 focused on a defined 
1% of human genome sequence [56]; then, by 2012, 
ENCODE consortium expanded to the entire genome 
with an integrated ENCODE map allowing to compre-
hend the biochemical functions to 80% of the genome 
[57]. In 2009, a limited range of mouse ENCODE project 
was launched with the high value and use of experimental 
mice [58]. Since 2012, both human and mouse ENCODE 
projects have initiated related programs to broaden and 
deepen their respective efforts [59, 60]. Based on these, 
the ENCODE project has given researchers insight into 
how the human genome functions. As researchers learn 
more about the regulation of gene activity and how 
genes are expressed, the effects of the entire genome on 
human health will become clear. Recently, ENCODE has 
incorporated and processed the data from Roadmap Epi-
genomics Project which accord to ENCODE standards. 
ENCODE data are available at ‘encodeproject.org’ and 
can be visualized using the University of California, Santa 
Cruz (UCSC) genome browser (genome.ucsc.edu).
Epigenome research projects: advances 
from ENCODE
Roadmap epigenomics program
The ENCODE project produced a number of papers in 
high-profile journals, e.g., Nature, Science, Cell, Genome 
Biology, Genome Research, and the Journal of Biologi-
cal Chemistry, reporting over 1,650 experiments using 
147 cell lines detailing functional features, including 
gene transcription, expression, transcription factor bind-
ing factors, chromatin conformation, DNA methylation, 
histone modification, and more [61, 62]. The large-
scale mapping of epigenome started in 2003 as a part of 
ENCODE; many researchers have suggested the impor-
tance of studies of functional elements in the epigenome 
and associations with development and disease [63]. Epi-
genomics is the study of the complete set of epigenetic 
modifications at the whole genome level, known as the 
epigenome [64]. Improvements in research technology 
for genome-scale analyses have prompted researchers to 
develop a roadmap for gene regulation and other regu-
latory elements. Five years after launching ENCODE, 
the NIH funded a second large public project referred 
to as the ‘Roadmap Epigenomics Program (2008) (www. 
roadm apepi genom ics. org)’ (Fig.  3), which has already 
ENCODE, Encyclopedia of DNA Element; IHEC, International Human Epigenome Consortium
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Fig. 3 Perspectives of epigenome research. Epigenome researches in the past and in progress
Page 6 of 14Cho et al. Clin Epigenet           (2021) 13:92 
contributed 61 complete epigenomes as of 2012, and the 
compilation of the “Human Epigenome Atlas” is in pro-
gress. Unfortunately, oral and maxillofacial regions have 
been excluded from the atlas work; therefore, more active 
genome-wide studies using appropriate dental samples 
and data processing techniques in the dental field are 
needed to keep pace with current advances. Roadmap 
Epigenome data sets are available at National Center for 
Biotechnology Information Gene Expression Omnibus 
(www. ncbi. nlm. nih. gov/ geo/ roadm ap/ epige nomics).
International human epigenome consortium
Following the NIH Roadmap Epigenomics Program 
(2008), the International Human Epigenome Consor-
tium (IHEC) was launched in 2010 (Fig. 3) [65]. IHEC is 
a global consortium, which aims to provide a free access 
to high-resolution reference human epigenome maps for 
a broad spectrum of human cell types and a wide range 
of developmental stages with respect to environmental 
variation. Several countries, including Canada, European 
Union, Germany, Hong Kong, Japan, Singapore, South 
Korea, and USA, have participated in contributing ref-
erence epigenomes. Recently, the IHEC coordinated the 
production of a catalog of their studies (http:// www. cell. 
com/ conso rtium/ IHEC), which describes epigenetic 
molecular mechanisms and computational tools for 
various disease conditions. More details are available at 
IHEC official homepage (http:// ihec- epige nomes. org/).
Next‑generation sequencing approaches to epigenomics
The epigenetic field was an early adopter of new molecu-
lar biological technology. Next-generation sequencing 
(NGS) techniques have placed epigenomics at the fore-
front of current research. NGS-based epigenome stud-
ies have provided detailed and multidisciplinary views of 
epigenetic modifications for the genomes of various cell 
types [66]. Representative epigenetic factors, i.e., DNA 
methylation and histone modifications, are routinely 
investigated genome-wide using NGS technology. Com-
pared to the histone modification profile, relatively more 
approaches for DNA methylation profiling using NGS 
platforms have been introduced.
DNA methylation profiling
With the development of microarray hybridization 
technology, DNA methylation studies have been scaled 
up to the genome-wide level. It is possible to construct 
genomic maps of DNA methylation with a single base 
resolution [67]. Genome-wide analyses of DNA meth-
ylation are divided into three general types, i.e., affinity 
enrichment, methyl-sensitive restriction enzymatic reac-
tion, and direct bisulfite conversion [68].
(1) Affinity enrichment-based methods: This technique 
uses methyl CpG binding domain (MBD) proteins 
or 5′-methyl cytosine-specific antibodies to enrich 
methylated DNA regions.
• Microarray: MBD or Methylated DNA Immuno-
precipitation (MeDIP) ChIP.
• High-throughput sequencing: MBDCap-seq 
[69], MethylCap-seq [70], MeDIP seq [71].
(2) Restriction enzyme-based methods: This technique 
uses the differential digestion properties of meth-
ylation-sensitive restriction enzymes (MREs). We 
can search MREs in the New England BioLabs data-
bases (https:// www. neb. com/ tools- and- resou rces/ 
selec tion- charts/ dam- dcm- and- cpg- methy lation). 
MRE-based methods have been coupled with NGS 
techniques to estimate genome-wide DNA meth-
ylation levels [72].
(3) Bisulfite conversion methods: This technique is 
based on changes in the methylated and unmeth-
ylated cytosine with sodium bisulfite treatment. 
It is used to study genome-wide methylation, e.g., 
by methylation arrays, whole-genome bisulfite 
sequencing (WGBS) [73], and reduced-representa-
tion bisulfite sequencing (RRBS) [74].
Histone modification profiling
By combining chromatin immunoprecipitation (ChIP) 
assays with sequencing technology, ChIP sequencing 
(ChIP-Seq) is a powerful tool for analyzing genome-
wide DNA binding sites for transcription factors and 
other associated proteins [75]. ChIP-seq recognizes the 
binding sites of DNA- or histone-associated proteins 
and provides a global binding map for given proteins. 
Unlike other approaches, ChIP-seq does not require 
prior knowledge, e.g., to make probes from known 
sequences. The application of NGS to ChIP has pro-
vided insights into the development of disease and bio-
logical mechanisms on a genome-wide scale [76].
Non‑coding RNAs (ncRNAs) profiling
Advances in sequencing technologies enabled to dis-
cover thousands of unannotated non-coding tran-
scripts. RNA sequencing (RNA-seq) is a major 
transcriptome profiling system than polymerase chain 
reaction (PCR) or microarray, and useful to identify the 
novel transcript. For antisense ncRNA identification, 
strand-specific RNA-seq is recommended [77].
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Epigenetic studies in periodontology: from specific 
genes to a genome‑wide approach
Epigenetics is regarded as a new frontier in den-
tistry [78]. In particular, the periodontal research field 
adopted epigenetic approaches relatively early. Epi-
genetic events regulate gene expression by chromatin 
remodeling and selective gene activation or inactiva-
tion [79]. These events may induce modifications in the 
cytokine profile and immune mechanisms and may 
thereby contribute to the pathogenesis of various infec-
tious and inflammatory diseases [80–84]. Because most 
periodontal diseases are initiated by the bacterial infec-
tion and inflammatory processes, which are associated 
with individual differences and environmental risk fac-
tors, epigenetic studies could help clarify the pathogen-
eses [4, 85].
DNA methylation and periodontal disease
Most studies of DNA methylation have focused on 
specific genes in human samples using methylation-
specific PCR (MSP), bisulfite-specific PCR (BSP), meth-
ylation-sensitive restriction enzyme-PCR (MSRE-PCR), 
and combined bisulfite restriction analysis (COBRA) 
(Table  1). However, this approach was limited for anal-
yses of the entire region at the low-throughput level. 
Advances in sequencing technology have broadened 
the target for epigenetic studies from specific genes to 
genome-wide analyses. Barros et al. performed a genome-
wide CpG methylation assay to compare healthy gingival 
tissues and periodontally diseased gingival tissues [4]. 
De Souza et  al. tried high-throughput DNA analysis in 
chronic periodontitis, indicating that variations in DNA 
methylation pattern between healthy and periodontitis 
are higher in genes related to the immune-inflammatory 
process [86]. In addition, as combined analysis about 
both DNA-methylation and gene-expression patterns, 
RNA and bisulfite sequencing were performed [39, 87]. 
In this study, comprehensive analysis including differen-
tial gene expression, DNA methylation, between-group 
correlation, gene set enrichment, and protein–protein 
interaction indicated that smoking-related changes in 
DNA methylation patterns and subsequent alterations 
in the extracellular matrix-related genes may be causally 
related to the increased susceptibility to periodontitis in 
smokers [39]. And in the comparison of periodontitis and 
peri-implantitis group, the analysis indicated that perio-
dontitis and peri-implantitis share biological similarities; 
however, hierarchical clustering between both disease 
groups revealed distinct molecular characteristics. These 
differences could be deduced from structural differ-
ences in natural tooth-bone and implant-bone. Addi-
tionally, smoking differentially affected periodontitis and 
peri-implantitis for impaired host-defense mechanisms 
[87].
Histone modifications and periodontal disease
The majority of epigenetic studies in periodontology have 
focused the changed in DNA methylation of target genes 
[42, 88, 89]. Generally, overexpressed pro-inflammatory 
cytokine genes in the inflamed gingival tissue showed 
decreased DNA methylation level. Relatively few studies 
have focused on histone modifications and periodontal 
disease compared with DNA methylation (Table 1). Some 
studies have used an animal periodontitis model with a 
histone deacetylase inhibitor (HDACi), suggesting the 
potential to use HDACi for therapeutic purposes [90], 
and evaluated histone modifications in periodontitis with 
periodontopathic bacteria [85]. Owing to the general lack 
of studies of histone modifications, further genome-wide 
studies are needed to confirm the effects of histone mod-
ifications in the field of periodontal research.
Non‑coding RNAs and periodontal disease
Long non-coding RNAs (lncRNAs) refers to a large class 
of transcripts over 200 nucleotides not encoding proteins 
[91]. Several studies have reported the aberrant expres-
sion of lncRNAs including POIR, MALAT1, ANRIL, 
FGD5-AS1, NEAT1, and NKILA in periodontitis patients 
compared with healthy subject [92, 93]. POIR lncRNA 
in periodontitis modulates osteoblast differentiation 
via miR-182 and subsequent reactivation of target gene, 
FoxO1 [94]. MALAT1 lncRNA increased in chronic peri-
odontitis modulating expression of pro-inflammatory 
cytokines via miR-20a and TLR pathway [95]. In addi-
tion, some studies have reported association between 
lncRNAs SNPs and inflammatory factors of periodontitis 
[96].
Periodontal disease and NCDs from an epigenetic 
perspective
Although periodontal disease is a major global public 
health issue with a high prevalence, high economic cost, 
and whole body consequences, it has a tendency to be 
neglected with respect to the total healthcare budget 
[97]. Non-communicable diseases (NCDs) are defined 
as medical conditions or diseases that are non-infec-
tious or non-transmissible, which could refer to chronic 
diseases with long durations and slow progress [98]. 
Chronic NCDs are the world’s leading causes of death 
and disability. Representative NCDs are cardiovascu-
lar diseases, respiratory diseases, and diabetes (Fig.  4). 
Many NCDs can be prevented by reducing common risk 
factors such as smoking, alcohol use, unhealthy foods, 
and physical inactivity. Approaches for the control and 
prevention of NCDs have been outlined in the United 
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Table 1 Overview of epigenetic studies in periodontology
Specific gene
Publication Methods Targets Results
(1) DNA methylation
Oliveira et al. [107] Methylation Specific PCR (MSP) Interleukin (IL)‑8 Individuals with chronic periodontitis, independent of 
smoking habit, have a higher percentage of hypo‑
methylation of the IL‑8 gene
Andia et al. [108] MSP IL‑8 A marked hypomethylated status in the promoter region 
of the IL‑8 gene was found in aggressive periodontitis
Loo et al. [109] MSP E‑cadherin, COX‑2 The methylation of CpG islands in E‑Cadherin and COX‑2 
genes in periodontitis patients occurs more frequently 
in periodontitis patients
Zhang et al. [110] Pyrosequencing (Interferon)IFN‑γ A hypomethylation profile within IFNG promoter region 
is related to an increase of IFNG transcription present 
in the chronic periodontitis
Zhang et al., 2010 [111] Bisulfite‑specific PCR (BSP) Prostaglandin‑endoperox‑
ide synthase (PTGS)2
The increase of methylation in chronic periodontitis was 
associated with a level of PTGS2 mRNA expression
de Oliveria et al. [112] Methylation‑Sensitive Restriction 
Enzyme‑PCR (MSRE‑PCR)
Toll‑like receptor (TLR)2, 
TLR4
No significant differences on DNA methylation status of 
the TRL2 and TRL4 gene promoters in periodontitis
Viana et al. [113] MSP, BSP IFN‑γ, IL‑10 No significant differences on DNA methylation status of 
the IFN‑γ and IL‑10 genes were observed
Ishida et al. [114] BSP IL‑6 Hypomethylated status of a single CpG in the IL‐6 
promoter region may lead to increased levels of serum 
IL‐6, implicating a role in the pathogenesis of chronic 
periodontitis
de Faria Amormino et al. [115] MSRE‑PCR TLR2 Positive correlation between the TLR2 methylation 
frequency and probing depth was observed in peri‑
odontitis
Stefani et al. [116] MSP IL‑6 The high expression of IL‑6 is an important factor related 
to chronic periodontitis, but was not associated with 
methylation status
Zhang et al. [117] BSP, Pyrosequencing Tumor necrosis factor 
(TNF)‑α
Increased methylation of TNF‑α in chronic periodontitis 
compared to those with gingival health
Baptista et al. [88] COmbined Bisulfite Restriction Analysis 
(COBRA)
suppressors of cytokine 
signaling (SOCS)‑1, long 
interspersed nuclear 
element (LINE)‑1
Different DNA methylation status of SOCS1 and LINE‑1 
was observed in infected oral environment
Andia et al. [89] MSRE‑PCR SOCS‑1,3 and LINE‑1 DNA methylation levels for SOCS1 and SOCS3 did not 
differ between healthy and periodontitis groups
Kobayasi et al. [118] BSP IL‑6 The increased expression of IL‑6 gene may be related to 
IL‑6 promoter hypomethylation in periodontitis
Kojima et al. [119] BSP TNF‑α The hypermethylated status of CpG motifs in the TNF‑α 
gene promoter in blood cells may be unique to Japa‑
nese adults with chronic periodontitis
Schulz et al. [120] PCR array 22 inflammatory candidate 
genes including CCL25 
and IL17C
Differential methylation pattern for CCL25 and IL17C in 
periodontitis was observed
Asa’ad et al. [121] Pyrosequencing LINE‑1, COX‑2, IFN‑γ, TNF‑α Periodontal therapy did not influence gene expression 
methylation of TNF‐α, IFN‐γ and LINE‐1 levels; how‑
ever, it significantly reduced COX‐2 methylation levels
Shaddox [122] Pyrosequencing TLR signaling genes (FADD,
MAP3K7,MYD88,IL6R,PPA
RA,IRAK1BP1,RIPK2)
Significant differences in methylation between LAP 
patients compared to healthy controls were observed
Li et al. [123] Pyrosequencing MMP‑9 and TIMP‑1 Positive correlation between methylation levels of 
MMP‑9 CpG islands and the severity of chronic peri‑
odontitis was found




Barros et al. [4] CpG methylation array The methylation status of some of these CpG 
regions suggests linkages with inflammatory 
pathways associated with acute and chronic 
inflammatory states
De Souza et al. [124] Genome‑wide methylation assay Variations in DNA methylation between healthy 
and periodontitis cases are higher in genes 
related to the immune‑inflammatory process
Cho et al. [39] RNA sequencing,
Reduced representation bisulfite sequencing (RRBS)
Smoking may change the transcription and 
methylation states of extracellular matrix (ECM) 
organization‑related genes, which exacerbated 
the periodontal condition
Cho et al. [87] RNA sequencing, RRBS Periodontitis and peri‑implantitis share biologi‑
cal similarities; however, hierarchical cluster‑
ing between the two disease groups revealed 
distinct molecular characteristics
Publications Methods Target Results
(2) Histone modification
Cantley et al. [90] Histone deacetylase inhibitor 
(HDACi) treatment to mouse 
model of periodontitis
Histone deacetylase HDACi effectively suppresses bone loss in the 
mouse model of periodontitis
Larsson et al. [125] Chromatin immunoprecipitation 
(ChIP) assay
IL‑10 LPS stimulation of B cells resulted in an increase in 
acetylation of H4 and methylation of H3
Martins et al. [85] Immunohistochemistry about 
histone modification in mouse 
periodontitis model
Acetylation in H3K9 Toll‑like receptors 1, 2, and 4 and the nucleotide‑
binding oligomerization domain protein 1 
induced histone acetylation in oral epithelial cells
Publications Methods Target Results
(3) Long non-coding RNAs (lncRNAs)
Gholami et al. [126] Real‑time PCR ANRIL lncRNA Expression of ANRIL was significantly lower in the 
blood of periodontitis
Li et al. [95] Real time PCR MALAT1 lncRNA MALAT1 up‑regulated in the gingival tissue of 
chronic periodontitis
MALAT1 enhances inflammatory cytokine produc‑
tion via miR‑20A and releasing TLR4
Wang et al. [94] Real‑time PCR POIR lncRNA POIR lncRNA may act as a competing endogenous 
RNA for miR‑182, leading to derepression of 
target gene, FoxO1
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Nations high-level meeting on NCDs in 2011, and gov-
ernments subsequently adopted a goal of a 25% relative 
reduction in premature mortality from NCDs by 2025 
(the “25 × 25” goal) [99]. To strengthen national efforts to 
reduce the load of NCDs, the 66th World Health Assem-
bly developed the WHO Global Action Plan for the Pre-
vention and Control of NCDs 2013–2020 [100], which is 
mostly concerned with the control of lifestyle factors. It is 
thought that lifestyle and environmental factors, beyond 
genetic traits, interact to determine the development 
of NCDs. As epigenetic changes are related to lifestyle 
and environmental factors, there may be a relationship 
between epigenetics and NCDs, and some recent human 
studies have reported that several NCDs have epige-
nome-wide associations with DNA methylation [101].
Most previous studies have focused on the inflamma-
tory-immune background of oral diseases such as dental 
caries and periodontitis in response to the bacterial chal-
lenges. However, there has been evidence that oral dis-
ease may not be directly associated with oral microbiome 
[42]. Current evidence indicates that epigenetics plays 
an important role in the disease mechanism and clini-
cal implication (Table  1). Interestingly, NCDs and oral 
diseases share common risk factors, such as smoking, 
alcohol, and poor diet (Fig.  4). The most common risk 
factors are environmental factors, which are candidate 
epigenetic factors [102]. Many reports have suggested 
that the common risk factors and shared pathological 
mechanisms could propose that there may be poten-
tial synergistic control of NCDs and periodontal disease 
[103–106]. We also found that smoking-related changes 
in DNA methylation patterns and subsequent altera-
tions in the expression of genes are causally related to 
the increased susceptibility to periodontitis and peri-
implantitis based on an NGS analysis [39, 87]. These 
results provide a rationale for conducting further studies 
using larger cohorts, the results of which will further elu-
cidate the critical mechanisms underlying the observed 
patterns related to environmental hazards. In addition, 
future studies may explore prevention of the occurrence 
and progress of the disease. Likewise, epigenetic research 
implies innovative insights to find novel biomarkers for 
early diagnosis, treatment, and prognosis.
Future perspectives
The ENCODE project provided researchers with new 
insight into how the genome functions, and allowed Epi-
genomic mapping using a systems biology approach to 
become an active international research trend. The field 
utilizes various new technologies to acquire information 
that cannot be revealed using classical forward or reverse 
genetic approaches. With the development of advanced 
sequencing technologies and bioinformatics applica-
tions, ‘omics’ profiling has catalyzed the concept of per-
sonalized medicine. Although international consortium 
is doing well now, it still has some limitations. As epi-
genetic landscape can be changed by environment fac-
tors, epigenome data has large individual variations that 
make it difficult to determine the reference. For accurate 









ORAL DISEASES      GENERAL DISEASESCommon risk factors
Fig. 4 Common risk factors approach in the oral and general diseases. Periodontal disease and non‑communicable diseases such as cardiovascular 
disease, diabetes, and respiratory disease share common risk factors including smoking, alcohol consumption, and poor dietary habits
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with well-classified and environmentally controlled cells 
or tissues is needed. In addition, complementary profil-
ing of epigenome, gene expression, and phenotype on 
target disease are required for the integration of map-
ping activities. Genetic and environmental interactions 
in periodontology are well under way, and epigenetic fac-
tors are expected to have increased roles in the diagnosis 
and treatment of periodontal disease, thereby extend-
ing the potential for personalized medicine. In order to 
actualize the personalized medicine, it is necessary to 
comprehensively analyze multi-omics data set including 
genome, epigenome, transcriptome, metabolome, micro-
biome, and proteome, etc., and to collaborate harmoni-
ously with bioinformaticians, scientists, and clinicians. 
Furthermore, advances in development of user-friendly 
and easy-to-handle software to utilize massive amount 
of data are also important for the practical application 
in various fields of research. Although epigenetic studies 
in periodontal disease have been conducted recently, in-
depth integrated analysis with other information already 
obtained will create synergistic effects. In addition, tar-
geted editing of epigenome to regulate gene expression 
could be the next possible step for disease control.
Conclusion
The comprehensive understanding of periodontal dis-
ease benefited from ENCODE and related epigenome 
research projects. Although these advances have not 
yet been realized in clinical settings, many trials have 
been performed to identify biomarkers for diagnosis as 
well as epi-drugs for the treatment and prevention of 
periodontal disease. These findings will provide novel 
insight into the etiology and pathologic mechanism by 
genetics and epigenetics. Several epidemiologic evi-
dences maintain that close link exists between NCDs 
and oral diseases. Furthermore, epigenetics, along with 
common risk factors, suggests that there may exist sys-
temic and oral cross talk. In line with global research 
trends, further comprehensive studies of the functional 
and regulatory elements involved in periodontal health 
conditions and systemic diseases by joining with the 
ENCODE project will help to identify new biological 
mechanisms and thereby to develop diagnostic bio-
markers and therapeutic strategies to promote oral 
health and general health, and expand the scope of 
ongoing large-scale research projects.
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